Quince Therapeutics (QNCX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

QNCX Quince Therapeutics

Watchlist

1.620
+0.310+23.66%

Close Oct 31 16:00 ET

1.640
+0.020+1.23%

Post 19:58 ET

70.11MMarket Cap-1285P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

This Six Flags Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
BenzingaOct 29 08:11 ET
Quince Therapeutics Initiated at Buy by Rodman & Renshaw
Dow JonesOct 29 07:44 ET · Ratings
Quince Therapeutics Price Target Announced at $11.00/Share by Rodman & Renshaw
Dow JonesOct 29 07:44 ET · Ratings
12 Health Care Stocks Moving In Thursday's After-Market Session
BenzingaOct 24 16:31 ET
Express News | EF Hutton Initiates Coverage On Quince Therapeutics With Buy Rating, Announces Price Target of $12
BenzingaOct 22 07:14 ET
Quince Therapeutics Analyst Ratings
BenzingaOct 22 07:12 ET · Ratings

Comments

WeiTheSaint469

Oct 30 09:27

in 1.316

$Quince Therapeutics (QNCX.US)$

Stock_Drift

Oct 24 13:20

Unusual Volume Ticks. 2:18pm

$Nukkleus (NUKK.US)$ $Fly-E (FLYE.US)$ $QuantumScape (QS.US)$ $Laird Superfood (LSF.US)$ $CCSC Technology International (CCTG.US)$ $Aligos Therapeutics (ALGS.US)$ $PureCycle Technologies (PCT.US)$ $Linkage Global (LGCB.US)$ $Quince Therapeutics (QNCX.US)$ $1847 Holdings (EFSH.US)$ $Nexalin Technology (NXL.US)$ $Nxu Inc (NXU.US)$ $Monopar Therapeutics (MNPR.US)$
📊⚡️📊

Jaguar8

Aug 15 07:55

NEWS

$Quince Therapeutics (QNCX.US)$
Quince Therapeutics Announces The Lancet Neurology Publication of Phase 3 ATTeST Clinical Trial Data Evaluating EryDex for the Treatment of Ataxia-Telangiectasia (A-T)
Quince Therapeutics (Nasdaq: QNCX) announced the publication of Phase 3 ATTeST clinical trial data in The Lancet Neurology, evaluating EryDex for treating Ataxia-Telangiectasia (A-T). The study, involving 175 participants across 22 institutions in 12 countries, demonstrated a favorable safety pro...

RoadToMoreMs

Aug 15 06:11

$Quince Therapeutics (QNCX.US)$ @Trytosaveabit what you think

Trytosaveabit

Jun 3 06:04

News

$Quince Therapeutics (QNCX.US)$ Benzinga· 1 min FDA Grants Fast Track Designation To Quince Therapeutics' EryDex System To Treat Ataxia-Telangiectasia